Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled date : 2021 - 07 - 27 save search
Lantern Pharma Reacquires Rights to Phase 2 Clinical Trial in Metastatic Prostate Cancer and Global Development & Commercialization of Irofulven (LP-100) from Allarity Therapeutics A/S
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
LTRN | News | $5.53 -4.16% 84K
|
Health Technology
|
| O: 0.62%
H: 1.32%
C: -2.48%
phase 2 commercialization prostate cancer cancer trial
Infinity Pharmaceuticals Presents Updated Data from Phase 2 MARIO-275 Trial in Urothelial Cancer (UC) and Phase 2 MARIO-3 Trial in Triple Negative Breast Cancer (TNBC)
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: -25.68%
H: 4.24%
C: -7.88%
phase 2 cancer breast cancer trial
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-27 (Crawled : 14:58) - fda.gov
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 0.21%
H: 0.14%
C: -0.05%
BMY | $48.875 -0.24% 11M
|
Health Technology
|
| O: -0.64%
H: 0.68%
C: 0.34%
ADCT | $4.76 -4.23% 210K
|
Health Technology
|
| O: -0.05%
H: 1.0%
C: -2.76%
YMAB | $15.17 -1.11% 98K
|
Health Technology
|
| O: -0.67%
H: 2.09%
C: -0.18%
SNY | News | $46.765 -1.94% 1.2M
|
Health Technology
|
| O: -0.54%
H: 0.65%
C: 0.49%
REGN | News | $908.32 0.11% 250K
|
Health Technology
|
| O: -1.6%
H: 2.25%
C: 2.2%
KPTI | $1.105 1.38% 1M
|
Health Technology
|
| O: -0.47%
H: 1.53%
C: -0.35%
INCY | $51.45 -0.39% 720K
|
Health Technology
|
| O: -0.41%
H: 0.14%
C: -0.84%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 2.34%
H: 0.37%
C: -1.69%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: -0.21%
H: 4.42%
C: 2.74%
BPMC | $92.385 0.1% 370K
|
Health Technology
|
| O: -0.12%
H: 0.58%
C: -0.16%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -1.17%
H: 2.55%
C: 0.59%
cancer approval
Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level
Published: 2021-07-27 (Crawled : 13:00) - prnewswire.com
ZCMD | $1.67 -2.91% 160K
|
Commercial Services
|
| O: -1.82%
H: 7.41%
C: 2.78%
treatment cancer breast cancer diagnostic
Bionano Genomics Announces a Record Number of Optical Genome Mapping Presentations Scheduled to Appear at the Annual Cancer Genomics Consortium Meeting from August 1st - 4th, 2021
Published: 2021-07-27 (Crawled : 12:00) - globenewswire.com
BNGO | $0.7594 -4.41% 720K
|
Health Technology
|
| O: -1.36%
H: 3.33%
C: -0.17%
presentation optical genomic cancer
Merck Announces Phase 3 KEYNOTE-355 Trial Met Primary Endpoint of Overall Survival (OS) in Patients with Metastatic Triple-Negative Breast Cancer Whose Tumors Expressed PD-L1 (CPS ≥10)
Published: 2021-07-27 (Crawled : 12:00) - biospace.com/
MRK | $127.345 0.37% 4.6M
|
Health Technology
|
| O: -0.09%
H: 1.24%
C: 0.88%
cancer phase 3 breast cancer trial
Verastem Oncology Announces Updated Phase 1/2 FRAME Study Data in Low Grade Serous Ovarian Cancer Selected for a Mini Oral Presentation at the European Society of Medical Oncology Congress 2021
Published: 2021-07-27 (Crawled : 12:00) - biospace.com/
VSTM | $9.39 -2.29% 51K
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: -1.8%
presentation europe phase 1 cancer ovarian cancer
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
SKIL 4 | $8.72 52.72% 410K
|
Information
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
RILY | $29.755 36.99% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.